Opinion

Video

Key Barriers in Implementing Guideline-Directed Cholesterol Treatment

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP,Kate Cabral, PharmD, BCCP, FACC, FCCP

Clinical pharmacists discuss how to address key barriers that get in the way of implementing guideline-directed cholesterol treatment.

Related Videos
5 experts in this video
5 experts in this video
5 experts in this video
5 experts in this video
Lipoprotein particles | Image Credit: © komgritch - stock.adobe.com
Image Credit: © jarun011 - stock.adobe.com
Image Credit: © Sweettymojidesign - stock.adobe.com
This series features 5 KOLs.
This series features 5 KOLs.
Related Content
Muvalaplin Significantly Lowers Lipoprotein(a) in Adults With High Risk for Cardiovascular Events
December 6th 2024

Muvalaplin Significantly Lowers Lipoprotein(a) in Adults With High Risk for Cardiovascular Events

Aislinn Antrim, MA, Assistant Managing Editor
Cholesterol buildup and blood cells | Image Credit: © VRAYVENUS - stock.adobe.com
December 2nd 2024

Zerlasiran Shows Significant Lipoprotein(a) Reduction in Phase 2 Trial

Alexandra Gerlach, Associate Editor
FCS, Plozasiran, Cholesterol, Familial Chylomicronemia Syndrome| Image Credit: © ugreen | stock.adobe.com
November 22nd 2024

Arrowhead Pharmaceuticals Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome

Ashley Gallagher, Associate Editor
AHA 2024: Inclisiran Shows Efficacy, Improved Adherence for Reducing LDL-C
November 17th 2024

AHA 2024: Inclisiran Shows Efficacy, Improved Adherence for Reducing LDL-C

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: Encourage Patients to Take Ownership of ASCVD, Medication Adherence
November 16th 2024

AHA 2024: Encourage Patients to Take Ownership of ASCVD, Medication Adherence

Aislinn Antrim, MA, Assistant Managing Editor
AHA 2024: Unexplained Changes in Cholesterol Could Help Identify Adults At Risk of Dementia
November 16th 2024

AHA 2024: Unexplained Changes in Cholesterol Could Help Identify Adults At Risk of Dementia

Aislinn Antrim, MA, Assistant Managing Editor